Bone Therapeutics SA BOTHE Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

08:03 EDT 19 Mar 2018 | BioPortfolio Reports


Bone Therapeutics SA Bone Therapeutics is a bone cell therapy company that develops autologous and allogeneic cell therapy products for orthopedics and bone diseases. The company's product pipeline includes PREOB, an autologous osteoblastic cell therapy product that is in two pivotal Phase IIB/III clinical trials for the treatment of osteonecrosis and nonunion fractures; and ALLOB, an allogeneic osteoblastic cell therapy product, which is in three Phase I/IIA proof of concept clinical trials for the treatment of delayedunion fractures, spinal fusion procedures, and revision spinal fusion. Bone Therapeutics conducts preclinical research on next generation product candidates such as combined cellmatrix products for large bone defects and maxillofacial applications. The company partners with biotech companies and research centers. Bone Therapeutics is headquartered in Gosselies, Belgium.

Bone Therapeutics SA Key Recent Developments

Feb 20,2018: Bone Therapeutics strengthens Board with the appointment of Jean Stephenne as Chairman

Jan 23,2018: Bone Therapeutics provides business outlook and announces its financial calendar for 2018

Nov 09,2017: Bone Therapeutics: Business Update for Third Quarter 2017

Aug 31,2017: Bone Therapeutics Appoints JeanLuc Vandebroek as Chief Financial Officer

Aug 31,2017: Bone Therapeutics Announces H1 Results for 2017

This comprehensive SWOT profile of Bone Therapeutics SA provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Bone Therapeutics SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends.

The profile contains critical company information including*,

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Original Article: Bone Therapeutics SA BOTHE Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300


More From BioPortfolio on "Bone Therapeutics SA BOTHE Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300"

Quick Search


Relevant Topics

Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...